CAREERS |E-NEWS SIGN UP | CONTACT US | HOME     


< Back to News

Delivra Signs Exclusive Licensing Deal for development of natural and medicinal Hemp Products
Thursday, May 11, 2017

Delivra Corp. (TSX VENTURE: DVA) and ARA-Avanti Rx Analytics Inc. ("Avanti") has announced a strategic partnership to develop a unique suite of standardized natural and medicinal products for the medical pain-related research, development, and commercialization markets, using hemp. Read News Release here.